PCN118 Budget IMPACT Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory B-Cell Precursor ACUTE Lymphoblastic Leukemia in the Netherlands
Abstract
Authors
I. van Oostrum K. De Lameillieure T.A. Russell-Smith